You are here

Diabetes and Vascular Disease Research

Diabetes and Vascular Disease Research

2017 Impact Factor: 3.340
2017 Ranking: 56/143 in Endocrinology & Metabolism | 19/65 in Peripheral Vascular Disease
Source: Journal Citation Reports®, 2018 release, a Clarivate Analytics product; Indexed in PubMed: MEDLINE

Editor In Chief
Peter Grant University of Leeds, UK
Diabetes Editor
Clifford J Bailey Aston University, UK
Vascular Disease Editor
Nikolaus Marx University of Aachen, Germany
Clinical Trials Editor
Darren McGuire University of Texas Southwestern Medical Centre, USA
Pre-clinical Research Editor
Mark Cooper Monash University, Austalia
Assistant Editors
Richard Cubbon University of Leeds, UK
Stefano Del Prato University of Pisa, Italy
Odette Gore University of Texas Southwestern Medical Center, USA
Silvio Inzucchi Yale University School of Medicine, USA
Steve Marso Saint Luke's Hospital, USA
Linda Mellbin Karolinska Institute, Sweden
David Russell Leeds Teaching Hospitals NHS Trust and University of Leeds, UK
Bianca Rocca Catholic University School of Medicine, Italy
Ann Marie Schmidt Columbia University, USA
Katharina Schütt University Hospital Aachen, RWTH University, Germany
Associate Editor
Ramzi Ajjan Leeds University, UK
Editorial Assistant
Vicki Harper Leeds University, UK


eISSN: 17528984 | ISSN: 14791641 | Current volume: 15 | Current issue: 5 Frequency: Bi-monthly

Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title.

It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders, such as insulin resistance, are directly linked with assaults on the vessel wall and the development of vascular risk clustering.

Diabetes & Vascular Disease Research:

  • Links diabetes, its metabolic consequences and vascular outcomes
  • Original research in fields of insulin resistance and metabolic disorders
  • Promotes understanding of pathology, aetiology and management of thrombosis, hyperglycaemia, hypertension, dyslipidaemia and micro- and macrovascular consequences.

This journal is a member of the Committee on Publication Ethics (COPE).

Diabetes & Vascular Disease Research is the first international peer-reviewed journal to unite diabetes and vascular disease in a single title.

It mirrors the increasing recognition that diabetes and cardiovascular disease are a single entity in which diabetes and related disorders, such as insulin resistance, are directly linked with assaults on the vessel wall and the development of vascular risk clustering.

Diabetes & Vascular Disease Research:

  • Links diabetes, its metabolic consequences and vascular outcomes
  • Original research in fields of insulin resistance and metabolic disorders
  • Promotes understanding of pathology, aetiology and management of thrombosis, hyperglycaemia, hypertension, dyslipidaemia and micro- and macrovascular consequences.
Editorial Board
George Alberti Newcastle University Medical School, UK
Carlos Alvarez University of Texas, Southwestern Medical Center, USA
Lina Badimon Hospital de la Santa Creu I Sant Pau, Spain
Cora Beckers University of Leeds, UK
Angelyn Bethel University of Oxford, UK
Ian De Boer University of Washington, USA
Antonio Ceriello Warwick University, UK
Mansoor Husain University of Toronto, Canada
Eri Toda Kato Brigham and Women's Hospital, USA
Mark Kearney Leeds University, UK
Mikhail Kosiborod Saint Luke's Mid America Heart Institute, USA
Andrew J Krentz University of Bedfordshire, UK
Lawrence A. Leiter St Michael's Hospital, Canada
Peter Libby Brigham and Women's Hospital, USA
Ildiko Lingvay University of Texas, Southwestern Medical Center, USA
John Nolan St James' Hospital, Ireland
John Petrie University of Glasgow, UK
Carolyn Lam Su Ping National University Heart Centre, Singapore
Jorge Plutzky Harvard Medical School, USA
Paul M Ridker Brigham & Women's Hospital, USA
Lars Ryden Karolinska University Hospital, Sweden
Ulf Smith The Sahlgrenska Academy, Sweden
Bart Staels Universiti Lille Nord de France, France
E Standl Diabetes Research Institute, Germany
George Steiner WHO Collaborative Center, Canada
J E Tooke Peninsula Medical School, UK
Harvey White University of Pittsburgh School of Medicine, USA
Paul Zimmet International Diabetes Insitute, Australia
  • EMBASE/Excerpta Medica
  • Index Medicus
  • Index Medicus (Ceased 2004)
  • MEDLINE
  • Scopus
  • Manuscript Submission Guidelines: Diabetes and Vascular Disease Research

    This Journal is a member of the Committee on Publication Ethics.

    This Journal recommends that authors follow the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals formulated by the International Committee of Medical Journal Editors (ICMJE).

    Please read the guidelines below then visit the Journal’s submission site http://mc.manuscriptcentral.com/dvdres to upload your manuscript. Please note that manuscripts not conforming to these guidelines may be returned.

    Only manuscripts of sufficient quality that meet the aims and scope of Diabetes and Vascular Disease Research will be reviewed.

    Publication Charge

    Please note that Diabetes & Vascular Disease Research will be implementing a publication charge on papers that are submitted on or after April 1st 2016 and subsequently accepted for publication after peer-review. We will be offering an introductory publication charge rate of $550, reduced from the full rate of $950 for a limited time. This charge will support the cost of publication. It is payable upon acceptance and subject to VAT* where applicable. 

    Please note that authors of revised papers, who submitted the original manuscript prior to April 1st 2016 will not incur this charge. Authors who opt to publish their paper as Open Access via SAGE Choice will only be required to pay the SAGE Choice fee and therefore will also be exempt from the Publication Charge.

    *If the paying author/institution is based in the European Union, to comply with European law, Value Added Tax must be added to the publishing charge. Providing a VAT registration number will allow an institution to avoid paying this tax, except for UK institutions. All invoices will be issued in GBP.

    As part of the submission process you will be required to warrant that you are submitting your original work, that you have the rights in the work, that you are submitting the work for first publication in the Journal and that it is not being considered for publication elsewhere and has not already been published elsewhere, and that you have obtained and can supply all necessary permissions for the reproduction of any copyright works not owned by you.

    1. What do we publish?
      1.1 Aims & Scope
      1.2 Article types
      1.3 Writing your paper
    2. Editorial policies
      2.1 Peer review policy
      2.2 Authorship
      2.3 Acknowledgements
      2.4 Funding
      2.5 Declaration of conflicting interests
      2.6 Research ethics and patient consent
      2.7 Clinical trials
      2.8 Reporting guidelines
      2.9 Data
    3. Publishing policies
      3.1 Publication ethics
      3.2 Contributor's publishing agreement
      3.3 Open access and author archiving
    4. Preparing your manuscript
      4.1 Formatting
      4.2 Artwork, figures and other graphics
      4.3 Supplementary material
      4.4 Reference style
      4.5 English language editing services
    5. Submitting your manuscript
      5.1 ORCID
      5.2 Information required for completing your submission
      5.3 Permissions 
      5.4 Publication charge
    6. On acceptance and publication
      6.1 SAGE Production
      6.2 Online First publication
      6.3 Access to your published article
      6.4 Promoting your article
    7. Further information

    1. What do we publish?

    1.1 Aims & Scope

    Before submitting your manuscript to Diabetes and Vascular Disease Research, please ensure you have read the Aims & Scope.

    1.2 Article Types

    The journal publishes original papers, reviews, discussions of topical issues, case studies and meeting reports. The suggested word counts only refer to the body of the text and exclude references etc.

    1.1 Summary of manuscript structure

    Title page (title of article, author names - forename, initials, surname - author affiliations, author for correspondence - title, address, telephone and fax numbers, email). Sole author articles should be accompanied by a relatively recent photograph of the author (at least 55 mm x 70 mm in size and at a minimum resolution of 300 dpi).

    Originals, Reviews, Achieving Best Practice, Current Topics: Abstract 200 words, max. Key Words 6 max.; Abbreviations and Acronyms box (do not write in full in text); Key Messages 5 max.; Subheaded text, to include an Introduction and Conclusion/Discussion; References (ideally max. 30); Vancouver - <4 authors cite all, >4 authors cite first 3 et al.; Ref title. Journal year,vol:pages. Provide web addresses and month accessed. Tables - ideally submitted in Word. Figures - ideally submitted in PowerPoint using journal colours (pinks/maroon/grey) which can be modified to journal pantones by Production. Font styles should be consistent across all submitted figures. All figures and tables require legends and keys/abbreviations as appropriate. Photographs/Images - original image saved as .tiff or .eps file (minimum resolution 300 dpi), see section 9.4.3 for more details.

    Short Reports: These are important preliminary data that justify early publication or briefer studies that warrant a short communication. Normally these manuscripts would be 1,500 words with 10-12 references and one figure or table.

    Editorials, Case studies: As above but omit Abstract, Key Words and Key Messages.

    Manuscripts should be structured as listed below.

    Original papers
    Should include:

      • Title page.
      • Abstract (200 words): a short inclusive statement suitable for direct electronic abstracting identifying the purpose of the study, key methods, the main results and the main conclusion.
      • Key words: maximum of 6 key words for indexing.
      • Introduction: concise description of background, sufficient for the non-specialist to appreciate the context of the work. Clear statement of the purpose of the study.
      • Methods: a brief description of study design, procedures, analytical techniques and statistical evaluation.
      • Results: a clear account of the study findings using quantitative language where possible and cross-referenced to tables and figures (ideally in PowerPoint using journal colours).
      • Discussion: an interpretation of the study placed within the context of current knowledge leading to specific conclusions where possible.
      • Each of the above sections should use subheadings as appropriate
      • Acknowledgements.
      • References (ideally max. 30), figures and tables (see 9.4.3 for more details).

    Reviews, Achieving Best Practice and Current Topics 
    Should include:

      • Title page as above. Abbreviations & Acronyms box as necessary.
      • Abstract (200 words): setting out the scope, key messages and conclusions of the review.
      • Body of text: liberally partitioned with headings and subheadings leading to a synopsis with conclusions at the end.

    Reviews ~2,500 words; Ach Best Pract 1,000-2,000 words; Curr Top 500-1,500 words
    Should include:

      • Key messages: in a separate box itemising 2-5 very short principal points.
      • Acknowledgements.
      • References (ideally max. 30), figures and tables (see 9.4.3 for more details).

    Editorial
    Should include:

      • Title page as above. Abbreviations & Acronyms box as necessary.
      • Body of text: 500-2,500 words, liberally partitioned with headings and subheadings leading to a synopsis with conclusions at the end.
      • References (ideally max. 30), figures and tables (see 9.4.3 for more details).

    Case Study
    Should include:

      • Title page as above. Abbreviations & Acronyms box if necessary - if abbreviations only used once, write in full in text.
      • Introduction/case history as appropriate (see published studies). 200-500 words. Succinct Conclusion/Discussion containing the key learning points provided by the case  If you are considering a longer Case study please follow all guidance for an Achieving Best Practice article.
      • Photograph/Image (original image saved as .tiff or .eps file - minimum resolution of 300 dpi - for scanned photographs see 9.4.3).
      • References (ideally max. 5), photographs, figures and tables (see 9.4.3 for more details).

    If you would like to discuss your paper prior to submission contact the Editor-in-Chief (p.j.grant@leeds.ac.uk) or Editor’s Assistant (V.L.Harper@leeds.ac.uk).

    1.3 Writing your paper

    The SAGE Author Gateway has some general advice and on how to get published, plus links to further resources.

    1.3.1 Make your article discoverable

    When writing up your paper, think about how you can make it discoverable. The title, keywords and abstract are key to ensuring readers find your article through search engines such as Google. For information and guidance on how best to title your article, write your abstract and select your keywords, have a look at this page on the Gateway: How to Help Readers Find Your Article Online.

    Back to top

    2. Editorial policies

    2.1 Peer review policy

    Diabetes & Vascular Disease Research operates a single-blind reviewing policy in which the reviewer's name is always concealed from the submitting author. Manuscripts are initially assigned to either the Editor-in-Chief who will make a decision regarding whether the manuscript fits within the aims and scope of the journal and is of sufficient priority to warrant peer review. At this stage some manuscripts may be immediately rejected. Papers which pass this initial check will then be assigned to either the Editor-in-Chief or a Section Editor who will manage the assignment of peer reviewers; each manuscript is reviewed by at least two referees. The Section Editor will then make a recommendation to the Editor-in-Chief regarding publication, primarily based on the reviewers comments. The Editor-in-Chief will make his final decision based on both this recommendation and the comments of the reviewers.

    As part of the submission process you will be asked to provide the names of peers who could be called upon to review your manuscript. Recommended reviewers should be experts in their fields and should be able to provide an objective assessment of the manuscript. Please be aware of any conflicts of interest when recommending reviewers. Examples of conflicts of interest include (but are not limited to) the below: 

      • The reviewer should have no prior knowledge of your submission
      • The reviewer should not have recently collaborated with any of the authors
      • Reviewer nominees from the same institution as any of the authors are not permitted

    Please note that the Editors are not obliged to invite/reject any recommended/opposed reviewers to assess your manuscript.

    2.2 Authorship

    SECTION FOR STM JOURNALS: Papers should only be submitted for consideration once consent is given by all contributing authors. Those submitting papers should carefully check that all those whose work contributed to the paper are acknowledged as contributing authors.

    The list of authors should include all those who can legitimately claim authorship. This is all those who:

        1. Made a substantial contribution to the concept or design of the work; or acquisition, analysis or interpretation of data,
        2. Drafted the article or revised it critically for important intellectual content,
        3. Approved the version to be published,
        4. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content.

    Authors should meet the conditions of all of the points above. When a large, multicentre group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript. These individuals should fully meet the criteria for authorship.

    Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship, although all contributors who do not meet the criteria for authorship should be listed in the Acknowledgments section. Please refer to the International Committee of Medical Journal Editors (ICMJE) authorship guidelines for more information on authorship.

    2.3 Acknowledgements

    All contributors who do not meet the criteria for authorship should be listed in an Acknowledgements section. Examples of those who might be acknowledged include a person who provided purely technical help, or a department chair who provided only general support.

    Any acknowledgements should appear first at the end of your article prior to your Declaration of Conflicting Interests (if applicable), any notes and your References.

    2.3.1 Writing assistance

    Individuals who provided writing assistance, e.g. from a specialist communications company, do not qualify as authors and so should be included in the Acknowledgements section. Authors must disclose any writing assistance – including the individual’s name, company and level of input – and identify the entity that paid for this assistance. It is not necessary to disclose use of language polishing services.

    2.4 Funding

    Diabetes and Vascular Disease Research requires all authors to acknowledge their funding in a consistent fashion under a separate heading. Please visit the Funding Acknowledgements page on the SAGE Journal Author Gateway to confirm the format of the acknowledgment text in the event of funding, or state that: This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. 

    2.5 Declaration of conflicting interests

    It is the policy of Diabetes and Vascular Disease Research to require a declaration of conflicting interests from all authors enabling a statement to be carried within the paginated pages of all published articles.

    Please ensure that a ‘Declaration of Conflicting Interests’ statement is included at the end of your manuscript, after any acknowledgements and prior to the references. If no conflict exists, please state that ‘The Author(s) declare(s) that there is no conflict of interest’. For guidance on conflict of interest statements, please see the ICMJE recommendations here.

    2.6 Research ethics and patient consent

    Medical research involving human subjects must be conducted according to the World Medical Association Declaration of Helsinki.

    Submitted manuscripts should conform to the ICMJE Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals, and all papers reporting animal and/or human studies must state in the methods section that the relevant Ethics Committee or Institutional Review Board provided (or waived) approval. Please ensure that you have provided the full name and institution of the review committee, in addition to the approval number.

    For research articles, authors are also required to state in the methods section whether participants provided informed consent and whether the consent was written or verbal.

    Information on informed consent to report individual cases or case series should be included in the manuscript text. A statement is required regarding whether written informed consent for patient information and images to be published was provided by the patient(s) or a legally authorized representative.

    Patients have a right to privacy that should not be infringed without informed consent. Identifying information, including patients' names, initials, or hospital numbers, should not be published in written descriptions, photographs, and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian) gives written informed consent for publication. Informed consent for this purpose requires that a patient who is identifiable be shown the manuscript to be published.

    Identifying details should be omitted if they are not essential. Complete anonymity is difficult to achieve, however, and informed consent should be obtained if there is any doubt. For example, masking the eye region in photographs of patients is inadequate protection of anonymity. If identifying characteristics are altered to protect anonymity, such as in genetic pedigrees, authors should provide assurance that alterations do not distort scientific meaning and Editors should so note. When informed consent has been obtained it should be indicated in the submitted article.

    Case studies are not the only kinds of article to which this rule will be applied, but they will be subject to additional scrutiny. Not only should submissions be accompanied by a statement of consent, but the Editor also expects to be informed about the measures that have been taken to anonymize the details that could have led to parties being identified. He also reserves the right to work with the authors to make additional anonymising changes as they or the reviewers see fit. The Editor may also ask authors to remove personal information that, whilst interesting and colourful, does not add to the substance of an article, but does increase the likelihood of parties being identified. The exception to this will be where the patient has indicated in writing that she/he wants to be identified, has read the material, has discussed the consequences of being identified, and has agreed to the disclosure of all the personal information contained in the article. 

    Please also refer to the ICMJE Recommendations for the Protection of Research Participants.

    All research involving animals submitted for publication must be approved by an ethics committee with oversight of the facility in which the studies were conducted. The journal has adopted the Consensus Author Guidelines on Animal Ethics and Welfare for Veterinary Journals published by the International Association of Veterinary Editors.

    2.7 Clinical trials

    Diabetes and Vascular Disease Research conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.

    2.8 Reporting guidelines

    The relevant EQUATOR Network reporting guidelines should be followed depending on the type of study. For example, all randomized controlled trials submitted for publication should include a completed CONSORT flow chart as a cited figure and the completed CONSORT checklist should be uploaded with your submission as a supplementary file. Systematic reviews and meta-analyses should include the completed PRISMA flow chart as a cited figure and the completed PRISMA checklist should be uploaded with your submission as a supplementary file. The EQUATOR wizard can help you identify the appropriate guideline.

    Other resources can be found at NLM’s Research Reporting Guidelines and Initiatives.

    2.9 Data

    SAGE acknowledges the importance of research data availability as an integral part of the research and verification process for academic journal articles.

    Diabetes and Vascular Disease Research  requests all authors submitting any primary data used in their research articles to be published in the online version of the journal, or provide detailed information in their articles on how the data can be obtained. This information should include links to third-party data repositories or detailed contact information for third-party data sources. Data available only on an author-maintained website will need to be loaded onto either the journal’s platform or a third-party platform to ensure continuing accessibility. Examples of data types include but are not limited to statistical data files, replication code, text files, audio files, images, videos, appendices, and additional charts and graphs necessary to understand the original research. The editors can also grant exceptions for data that cannot legally or ethically be released. All data submitted should comply with Institutional or Ethical Review Board requirements and applicable government regulations.

    Back to top

    3. Publishing Policies

    3.1 Publication ethics

    SAGE is committed to upholding the integrity of the academic record. We encourage authors to refer to the Committee on Publication Ethics’ International Standards for Authors and view the Publication Ethics page on the SAGE Author Gateway.

    3.1.1 Plagiarism

    and SAGE take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of published articles. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked with duplication-checking software. Where an article, for example, is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where the authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article; taking up the matter with the head of department or dean of the author's institution and/or relevant academic bodies or societies; or taking appropriate legal action.

    3.1.2 Prior publication

    If material has been previously published it is not generally acceptable for publication in a SAGE journal. However, there are certain circumstances where previously published material can be considered for publication. Please refer to the guidance on the SAGE Author Gateway or if in doubt, contact the Editor at the address given below.

    3.2 Contributor's publishing agreement

    Before publication, SAGE requires the author as the rights holder to sign a Journal Contributor’s Publishing Agreement. SAGE’s Journal Contributor’s Publishing Agreement is an exclusive licence agreement which means that the author retains copyright in the work but grants SAGE the sole and exclusive right and licence to publish for the full legal term of copyright. Exceptions may exist where an assignment of copyright is required or preferred by a proprietor other than SAGE. In this case copyright in the work will be assigned from the author to the society. For more information please visit the SAGE Author Gateway.

    3.3 Open access and author archiving

    Diabetes and Vascular Disease Research offers optional open access publishing via the SAGE Choice programme. For more information please visit the SAGE Choice website. Please note that papers published as open access via SAGE Choice are exempt from the Publication Charge and therefore will only be required to pay the SAGE Choice fee. For information on funding body compliance, and depositing your article in repositories, please visit SAGE Publishing Policies on our Journal Author Gateway.

    Back to top

    4. Preparing your manuscript for submission

    4.1 Formatting

    The preferred format for your manuscript is Word. LaTeX files are also accepted. Word and (La)Tex templates are available on the Manuscript Submission Guidelines page of our Author Gateway.

    4.2 Artwork, figures and other graphics

    For guidance on the preparation of illustrations, pictures and graphs in electronic format, please visit SAGE’s Manuscript Submission Guidelines.  

    Figures supplied in colour will appear in colour online regardless of whether or not these illustrations are reproduced in colour in the printed version. For specifically requested colour reproduction in print, you will receive information regarding the costs from SAGE after receipt of your accepted article.

    Images should be supplied as bitmap based files (i.e. with .tiff or .jpeg extension) with a resolution of at least 300 dpi (dots per inch). Line art should be supplied as vector-based, separate .eps files (not as .tiff files, and not only inserted in the Word or pdf file), with a resolution of 600 dpi. Images should be clear, legible, in focus, free of pixilation and not too light or dark.

    In text: tables and figures are either inserted as part of a sentence, for example table 1 or in parentheses for example (figure 1). Each table should carry a descriptive heading. Each figure should be submitted electronically.

    Any artwork provided should be in .tiff format. Each piece of artwork should be saved as a separate file. No artwork should be included in the text files. Revised manuscripts should be resubmitted as executable files only, i.e. MS Word.

    Illustrations: Computer generated graphics. All art that must be sent electronically in .eps or .tiff files, at 300 dpi resolution, for superior reproduction. Please indicate the position of all figures in the text. When graphs or histograms are submitted the numerical data on which they are based should be supplied.

    Line drawings: Originals should always be submitted. Wherever possible, graphs should be boxed in, and scale divisions should be marked on the inside of the boxes. Grids should not be shown. Insofar as possible, explanations should be placed in the legend. Original drawings should not be larger than 20 25 cm (8 10 in). Lettering should be planned for 50% reduction; text must be readable after reduction. Text must be readable after reduction.

    Photographs: All photographs should be in a high quality digital format of at least 300 dpi resolution. Patients in photographs should not be identifiable and should have their eyes masked. Any identifiable photograph should be accompanied by written permission from the patient, parent or guardian. Photographs will only be printed in colour if the author bears the cost of reproduction, however if colour photographs are supplied they will appear as such online.

    Tables: Indicate in the margin of the text where tables should be positioned. Each table should have an explanatory caption, and be clearly numbered.

    4.3 Supplementary material

    This journal is able to host additional materials online (e.g. datasets, podcasts, videos, images etc) alongside the full-text of the article. For more information please refer to our guidelines on submitting supplementary files.

    4.4 Reference style

    Diabetes and Vascular Disease Research adheres to the SAGE Vancouver reference style. View the SAGE Vancouver guidelines to ensure your manuscript conforms to this reference style.

    If you use EndNote to manage references, you can download the SAGE Vancouver EndNote output file.

    4.5 English language editing services

    Authors seeking assistance with English language editing, translation, or figure and manuscript formatting to fit the journal’s specifications should consider using SAGE Language Services. Visit SAGE Language Services on our Journal Author Gateway for further information.

    Back to top

    5. Submitting your manuscript

    Diabetes and Vascular Disease Research is hosted on SAGE Track, a web based online submission and peer review system powered by ScholarOne™ Manuscripts. Visit http://mc.manuscriptcentral.com/dvdres  to login and submit your article online.

    IMPORTANT: Please check whether you already have an account in the system before trying to create a new one. If you have reviewed or authored for the journal in the past year it is likely that you will have had an account created.  For further guidance on submitting your manuscript online please visit ScholarOne Online Help.

    If you would like to discuss your paper prior to submission contact the Editor-in-Chief (p.j.grant@leeds.ac.uk) or Editorial Assistant (V.L.Harper@Leeds.ac.uk).

    If you seek advice on the submission process please contact the Editorial Assistant: V.L.Harper@Leeds.ac.uk

    5.1 ORCID

    As part of our commitment to ensuring an ethical, transparent and fair peer review process SAGE is a supporting member of ORCID, the Open Researcher and Contributor ID. ORCID provides a persistent digital identifier that distinguishes researchers from every other researcher and, through integration in key research workflows such as manuscript and grant submission, supports automated linkages between researchers and their professional activities ensuring that their work is recognised.

    We encourage all authors to add their ORCIDs to their SAGE Track accounts and include their ORCIDs as part of the submission process. If you don’t already have one you can create one here.

    5.2 Information required for completing your submission

    You will be asked to provide contact details and academic affiliations for all co-authors via the submission system and identify who is to be the corresponding author. These details must match what appears on your manuscript. At this stage please ensure you have included all the required statements and declarations and uploaded any additional supplementary files (including reporting guidelines where relevant).

    5.3 Permissions

    Please also ensure that you have obtained any necessary permission from copyright holders for reproducing any illustrations, tables, figures or lengthy quotations previously published elsewhere. For further information including guidance on fair dealing for criticism and review, please see the Copyright and Permissions page on the SAGE Author Gateway.

    5.4 Publication charge

    Please note that Diabetes & Vascular Disease Research will be implementing a publication charge on papers that are submitted on or after April 1st 2016 and subsequently accepted for publication after peer-review. We will be offering an introductory publication charge rate of $550, reduced from the full rate of $950 for a limited time. This charge will support the cost of publication. It is payable upon acceptance and subject to VAT* where applicable.

    Please note that authors of revised papers, who submitted the original manuscript prior to April 1st 2016 will not incur this charge.

    *If the paying author/institution is based in the European Union, to comply with European law, Value Added Tax must be added to the publishing charge. Providing a VAT registration number will allow an institution to avoid paying this tax, except for UK institutions. All invoices will be issued in GBP.

    Back to top

    6. On acceptance and publication

    6.1 SAGE Production

    Your SAGE Production Editor will keep you informed as to your article’s progress throughout the production process. Proofs will be sent by PDF to the corresponding author and should be returned promptly.  Authors are reminded to check their proofs carefully to confirm that all author information, including names, affiliations, sequence and contact details are correct, and that Funding and Conflict of Interest statements, if any, are accurate. Please note that if there are any changes to the author list at this stage all authors will be required to complete and sign a form authorising the change.

    6.2 Online First publication

    Online First allows final articles (completed and approved articles awaiting assignment to a future issue) to be published online prior to their inclusion in a journal issue, which significantly reduces the lead time between submission and publication. Visit the SAGE Journals help page for more details, including how to cite Online First articles.

    6.3 Access to your published article

    SAGE provides authors with online access to their final article.

    6.4 Promoting your article

    Publication is not the end of the process! You can help disseminate your paper and ensure it is as widely read and cited as possible. The SAGE Author Gateway has numerous resources to help you promote your work. Visit the Promote Your Article page on the Gateway for tips and advice. In addition, SAGE is partnered with Kudos, a free service that allows authors to explain, enrich, share, and measure the impact of their article. Find out how to maximise your article’s impact with Kudos

    Back to top

    7. Further information

    Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the Diabetes and Vascular Disease Research editorial office as follows:

    Vicki Harper
    Editorial Assistant
    V.L.Harper@Leeds.ac.uk

    Individual Subscription, Combined (Print & E-access)


    Institutional Subscription, E-access


    Institutional Subscription, Combined (Print & E-access)


    Individual, Single Print Issue


    Institutional, Single Print Issue